Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q1 2017 (← Previous) (Next →)

Filing Date: May 15, 2017

Total Value: $537M (100.0% shares, 0.0% debt)

Holdings (64)

XBI SPDR SERIES TRUST 11.6%
Value $62.41M Shares 900,000 Share Price $69.34 Est. Cost/Share — Unrealized @ Report Date —
IWM ISHARES TR 6.4%
Value $34.37M Shares 250,000 Share Price $137.48 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 4.4%
Value $23.57M Shares 100,000 Share Price $235.74 Est. Cost/Share — Unrealized @ Report Date —
— DBV TECHNOLOGIES S A 3.3%
Value $17.61M Shares 500,000 Share Price $35.22 Est. Cost/Share $35.76 Unrealized @ Report Date —
— AVEXIS INC 2.5%
Value $13.3M Shares 175,000 Share Price $76.03 Est. Cost/Share $46.75 Unrealized @ Report Date —
NBIX NEUROCRINE BIOSCIENCES INC 2.4%
Value $12.99M Shares 300,000 Share Price $43.30 Est. Cost/Share $42.84 Unrealized @ Report Date 0.0%
— CLOVIS ONCOLOGY INC 2.4%
Value $12.73M Shares 200,000 Share Price $63.67 Est. Cost/Share $16.16 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 2.3%
Value $12.6M Shares 1,500,000 Share Price $8.40 * Est. Cost/Share $4.04 Unrealized @ Report Date +72.1%
— SEATTLE GENETICS INC 2.3%
Value $12.57M Shares 200,000 Share Price $62.86 Est. Cost/Share $55.30 Unrealized @ Report Date —
ZBH ZIMMER BIOMET HLDGS INC 2.3%
Value $12.21M Shares 100,000 Share Price $122.11 * Est. Cost/Share $113.85 Unrealized @ Report Date -7.4%
ACAD ACADIA PHARMACEUTICALS INC 2.2%
Value $12.03M Shares 350,000 Share Price $34.38 * Est. Cost/Share $34.90 Unrealized @ Report Date +1.1%
BSX BOSTON SCIENTIFIC CORP 2.1%
Value $11.19M Shares 450,000 Share Price $24.87 * Est. Cost/Share $19.09 Unrealized @ Report Date +27.4%
— SPARK THERAPEUTICS INC 2.0%
Value $10.67M Shares 200,000 Share Price $53.34 Est. Cost/Share $51.96 Unrealized @ Report Date —
— ACCELERON PHARMA INC 2.0%
Value $10.59M Shares 400,000 Share Price $26.47 Est. Cost/Share $26.38 Unrealized @ Report Date —
— EPIZYME INC 1.9%
Value $10.29M Shares 600,000 Share Price $17.15 Est. Cost/Share $13.15 Unrealized @ Report Date —
— AERIE PHARMACEUTICALS INC 1.9%
Value $9.977M Shares 220,000 Share Price $45.35 Est. Cost/Share $37.77 Unrealized @ Report Date —
VRTX VERTEX PHARMACEUTICALS INC 1.8%
Value $9.842M Shares 90,000 Share Price $109.36 * Est. Cost/Share $88.04 Unrealized @ Report Date 0.0%
— IMMUNOMEDICS INC 1.8%
Value $9.705M Shares 1,500,000 Share Price $6.47 Est. Cost/Share $2.79 Unrealized @ Report Date —
MRK MERCK & CO INC 1.8%
Value $9.531M Shares 150,000 Share Price $63.54 * Est. Cost/Share $44.08 Unrealized @ Report Date +4.5%
— SPECTRANETICS CORP 1.8%
Value $9.464M Shares 325,000 Share Price $29.12 Est. Cost/Share $15.14 Unrealized @ Report Date —
— ENDOLOGIX INC 1.8%
Value $9.412M Shares 1,300,000 Share Price $7.24 Est. Cost/Share $7.24 Unrealized @ Report Date —
ENTA ENANTA PHARMACEUTICALS INC 1.7%
Value $9.24M Shares 300,000 Share Price $30.80 Est. Cost/Share $31.14 Unrealized @ Report Date 0.0%
— NUVASIVE INC 1.7%
Value $8.962M Shares 120,000 Share Price $74.68 Est. Cost/Share $57.34 Unrealized @ Report Date —
— LION BIOTECHNOLOGIES INC 1.7%
Value $8.94M Shares 1,200,000 Share Price $7.45 Est. Cost/Share $7.22 Unrealized @ Report Date —
— ADURO BIOTECH INC 1.6%
Value $8.6M Shares 800,000 Share Price $10.75 Est. Cost/Share $10.75 Unrealized @ Report Date —
PBYI PUMA BIOTECHNOLOGY INC 1.6%
Value $8.37M Shares 225,000 Share Price $37.20 Est. Cost/Share $36.49 Unrealized @ Report Date 0.0%
— GENMARK DIAGNOSTICS INC 1.6%
Value $8.333M Shares 650,000 Share Price $12.82 Est. Cost/Share $12.82 Unrealized @ Report Date —
BMY BRISTOL MYERS SQUIBB CO 1.5%
Value $8.157M Shares 150,000 Share Price $54.38 * Est. Cost/Share $39.53 Unrealized @ Report Date +1.0%
— NANOSTRING TECHNOLOGIES INC 1.5%
Value $7.948M Shares 400,000 Share Price $19.87 Est. Cost/Share $17.11 Unrealized @ Report Date —
— PORTOLA PHARMACEUTICALS INC 1.5%
Value $7.838M Shares 200,000 Share Price $39.19 Est. Cost/Share $39.19 Unrealized @ Report Date —
— TESARO INC 1.4%
Value $7.694M Shares 50,000 Share Price $153.88 Est. Cost/Share $84.06 Unrealized @ Report Date —
AGIO AGIOS PHARMACEUTICALS INC 1.4%
Value $7.3M Shares 125,000 Share Price $58.40 * Est. Cost/Share $52.47 Unrealized @ Report Date -8.6%
ACAD ACADIA PHARMACEUTICALS INC 1.3%
Value $7.124M Shares 207,200 Share Price $34.38 * Est. Cost/Share $34.90 Unrealized @ Report Date +1.1%
— SAGE THERAPEUTICS INC 1.3%
Value $7.107M Shares 100,000 Share Price $71.07 Est. Cost/Share $46.68 Unrealized @ Report Date —
— NOVADAQ TECHNOLOGIES INC 1.3%
Value $7.011M Shares 900,000 Share Price $7.79 Est. Cost/Share $7.79 Unrealized @ Report Date —
— RA PHARMACEUTICALS INC 1.2%
Value $6.387M Shares 300,000 Share Price $21.29 Est. Cost/Share $19.76 Unrealized @ Report Date —
— ACORDA THERAPEUTICS INC 1.2%
Value $6.3M Shares 300,000 Share Price $21.00 Est. Cost/Share $21.30 Unrealized @ Report Date —
— K2M GROUP HLDGS INC 1.1%
Value $5.845M Shares 285,000 Share Price $20.51 Est. Cost/Share $20.51 Unrealized @ Report Date —
— WRIGHT MED GROUP N V 1.1%
Value $5.757M Shares 185,000 Share Price $31.12 Est. Cost/Share $22.80 Unrealized @ Report Date —
PRTA PROTHENA CORP PLC 1.0%
Value $5.579M Shares 100,000 Share Price $55.79 * Est. Cost/Share $52.54 Unrealized @ Report Date 0.0%
— NXSTAGE MEDICAL INC 1.0%
Value $5.366M Shares 200,000 Share Price $26.83 Est. Cost/Share $26.83 Unrealized @ Report Date —
— SHIRE PLC 1.0%
Value $5.227M Shares 30,000 Share Price $174.23 Est. Cost/Share $170.38 Unrealized @ Report Date —
— ENTELLUS MED INC 1.0%
Value $5.175M Shares 375,000 Share Price $13.80 Est. Cost/Share $16.60 Unrealized @ Report Date —
INCY INCYTE CORP 0.9%
Value $4.678M Shares 35,000 Share Price $133.66 * Est. Cost/Share $116.27 Unrealized @ Report Date +9.5%
— SPECTRANETICS CORP 0.8%
Value $4.514M Shares 155,000 Share Price $29.12 Est. Cost/Share $15.14 Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 0.7%
Value $3.999M Shares 100,000 Share Price $39.99 Est. Cost/Share $39.99 Unrealized @ Report Date —
— ZOGENIX INC 0.7%
Value $3.96M Shares 365,000 Share Price $10.85 Est. Cost/Share $11.21 Unrealized @ Report Date —
COLL COLLEGIUM PHARMACEUTICAL INC 0.7%
Value $3.773M Shares 375,000 Share Price $10.06 * Est. Cost/Share $14.87 Unrealized @ Report Date 0.0%
— AQUINOX PHARMACEUTICALS INC 0.7%
Value $3.755M Shares 225,000 Share Price $16.69 Est. Cost/Share $13.36 Unrealized @ Report Date —
— RIGEL PHARMACEUTICALS INC 0.7%
Value $3.641M Shares 1,100,000 Share Price $3.31 Est. Cost/Share $2.62 Unrealized @ Report Date —
IRIX IRIDEX CORP 0.6%
Value $2.968M Shares 250,000 Share Price $11.87 * Est. Cost/Share $14.17 Unrealized @ Report Date -0.8%
— INTRA CELLULAR THERAPIES INC 0.5%
Value $2.438M Shares 150,000 Share Price $16.25 Est. Cost/Share $16.25 Unrealized @ Report Date —
— DERMIRA INC 0.4%
Value $2.217M Shares 65,000 Share Price $34.11 Est. Cost/Share $34.11 Unrealized @ Report Date —
— CYMABAY THERAPEUTICS INC 0.4%
Value $2.15M Shares 500,000 Share Price $4.30 Est. Cost/Share $4.30 Unrealized @ Report Date —
— CONFORMIS INC 0.4%
Value $2.088M Shares 400,000 Share Price $5.22 Est. Cost/Share $5.22 Unrealized @ Report Date —
PTCT PTC THERAPEUTICS INC 0.4%
Value $1.968M Shares 200,000 Share Price $9.84 * Est. Cost/Share $12.10 Unrealized @ Report Date 0.0%
— STEMLINE THERAPEUTICS INC 0.4%
Value $1.924M Shares 225,000 Share Price $8.55 Est. Cost/Share $8.55 Unrealized @ Report Date —
— CURRENCYSHARES SWISS FRANC T 0.3%
Value $1.835M Shares 19,300 Share Price $95.08 Est. Cost/Share $93.73 Unrealized @ Report Date —
— ZOSANO PHARMA CORP 0.3%
Value $1.786M Shares 940,000 Share Price $1.90 Est. Cost/Share $1.90 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 0.2%
Value $895K Shares 172,184 Share Price $5.20 Est. Cost/Share $13.43 Unrealized @ Report Date —
— AVEO PHARMACEUTICALS INC 0.2%
Value $885K Shares 1,500,000 Share Price $0.59 Est. Cost/Share $0.59 Unrealized @ Report Date —
— FOAMIX PHARMACEUTICALS LTD 0.1%
Value $619K Shares 125,000 Share Price $4.95 Est. Cost/Share $10.31 Unrealized @ Report Date —
XENE XENON PHARMACEUTICALS INC 0.1%
Value $600K Shares 150,000 Share Price $4.00 * Est. Cost/Share $7.72 Unrealized @ Report Date +1.8%
— AKARI THERAPEUTICS PLC 0.1%
Value $516K Shares 46,622 Share Price $11.07 Est. Cost/Share $18.60 Unrealized @ Report Date —